Atlas Trials

Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial

Clinical trial NCT02874989 · COMPLETED

Trial details

NCT number
NCT02874989
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis (IPF)
Start date
2016-12-16
Primary completion
2019-06-03
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.